Effects of parabulbar application of triamcinolone acetonide on uveitic macular edema with or without epiretinal membranesv

Jelena Paovic,Predrag Paovic,Vojislav Sredovic

ParametersExaminationandfollow-upInitial2nd3rd4thVE0.72±0.300.79±0.250.89±0.190.92±0.16IOP13.84±1.6615.34±3.7915.21±2.9113.74±1.59CFT297.75±69.45272.84±57.91275.49±39.33289.99±54.99AT305.59±27.26289.55±21.07296.27±14.52292.04±20.02VOL7.64±0.807.86±1.587.32±0.397.30±0.50

ParametersERMExaminationandfollow-upInitial2nd3rd4thVEWithout0.75±0.300.82±0.250.93±0.160.96±0.13With0.68±0.310.76±0.250.85±0.220.89±0.18Total0.72±0.300.79±0.250.89±0.190.92±0.16IOPWithout14.01±1.7216.16±4.2315.76±3.0813.84±1.75With13.66±1.5914.53±3.1214.66±2.6413.63±1.43Total13.84±1.6615.34±3.7915.21±2.9113.74±1.59CFTWithout277.91±54.66262.40±49.28260.77±19.37242.06±12.69With317.59±76.99283.28±64.09290.21±47.98337.92±35.65Total297.75±69.45272.84±57.91275.49±39.33289.99±54.99ATWithout293.47±26.09280.00±15.88288.63±10.83273.50±2.19With317.71±22.76299.11±21.38303.90±13.75310.58±10.24Total305.59±27.26289.55±21.07296.27±14.52292.04±20.02VOLWithout7.27±0.638.01±1.767.04±0.166.84±0.05With8.02±0.787.71±1.397.60±0.347.77±0.26Total7.64±0.807.86±1.587.32±0.397.30±0.50

ParametersVE1st2nd3rd4thIOP1st2nd3rd4th1st10.807b0.625b0.539b-0.020-0.079-0.052-0.1222nd0.807b10.744b0.698b-0.013-0.086-0.058-0.0783rd0.625b0.744b10.904b-0.009-0.0040.005-0.0544th0.539b0.698b0.904b10.0020.0300.0570.017

ParametersCFT1st2nd3rd4thAV1st2nd3rd4thVOL1st2nd3rd4th1st-0.192a-0.161-0.154-0.170a-0.250b-0.077-0.155-0.111-0.127-0.089-0.138-0.1112nd-0.164-0.204a-0.142-0.162-0.285b-0.153-0.154-0.105-0.157-0.125-0.121-0.1053rd-0.239b-0.332b-0.176a-0.306b-0.295b-0.225b-0.231b-0.232b-0.184a-0.133-0.230b-0.232b4th-0.128-0.272b-0.130-0.228b-0.213a-0.070-0.198a-0.196a-0.127-0.096-0.205a-0.196a